FMR LLC
Institutional investor · Portfolio as of Q3 2023
Top Holdings5,280 positions
Microsoft Corp | 215.9M | $68.2B | 5.9% | — | — | — | Increased 64 |
NVIDIA Corp | 129M | $56.1B | 4.9% | — | — | — | Decreased 0 |
Apple Inc | 298.3M | $51.1B | 4.4% | — | — | — | Decreased 0 |
Facebook Inc | 130.8M | $39.3B | 3.4% | — | — | — | Increased 61 |
Amazon.com Inc | 302.1M | $38.4B | 3.3% | — | — | — | Increased 63 |
Alphabet Inc | 227.3M | $29.7B | 2.6% | — | — | — | Increased 58 |
UnitedHealth Group Inc | 43.5M | $21.9B | 1.9% | — | — | — | Decreased 0 |
BERKSHIRE HATHAWAY INC CL A | 33,428 | $17.8B | 1.5% | — | — | — | Decreased 0 |
Eli Lilly & Co | 32.2M | $17.3B | 1.5% | — | — | — | Decreased 0 |
Exxon Mobil Corp | 145.2M | $17.1B | 1.5% | — | — | — | Increased 52 |
Alphabet Inc | 120.2M | $15.9B | 1.4% | — | — | — | Increased 52 |
Visa Inc | 50.4M | $11.6B | 1.0% | — | — | — | Increased 53 |
Netflix Inc | 22.4M | $8.5B | 0.7% | — | — | — | Decreased 0 |
Mastercard Inc | 20.8M | $8.2B | 0.7% | — | — | — | Decreased 0 |
Regeneron Pharmaceuticals Inc | 9.8M | $8.1B | 0.7% | — | — | — | Increased 48 |
salesforce.com Inc | 36.1M | $7.3B | 0.6% | — | — | — | Decreased 0 |
Tesla Inc | 29M | $7.3B | 0.6% | — | — | — | Increased 45 |
JPMorgan Chase & Co | 49.4M | $7.2B | 0.6% | — | — | — | Increased 45 |
Wells Fargo & Co | 174.1M | $7.1B | 0.6% | — | — | — | Decreased 0 |
General Electric Co | 63.6M | $7B | 0.6% | — | — | — | Decreased 0 |
FMR LLC manages $1.2T across 5280 positions as of Q3 2023. Top holdings: MSFT (5.9%), NVDA (4.9%), AAPL (4.4%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 416 new positions, 500 exits, 2440 increased. Top move: MSFT (INCREASED, conviction 64). Portfolio: $1.2T across 5280 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR